Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in TBPH — Theravance Biopharma, Inc.

CIK 1692234 Seattle, WA
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$411,281
+$348,407 QoQ
Shares Held
24,193
+524.5% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. TBPH ranks #159 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in TBPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $411,281 24,193
2026-03-31 $62,874 3,874
2025-12-31 $75,737 4,048
2025-09-30 $73,904 5,062
2025-06-30 $468,674 42,491
2025-03-31 $429,164 48,059
2024-12-31 $206,924 21,990
2024-09-30 $379,607 47,098
2024-06-30 $428,391 50,518
2024-03-31 $404,671 45,114
2023-12-31 $325,723 28,979
2023-09-30 $401,320 46,503
2023-06-30 $554,945 53,618
2023-03-31 $790,464 72,854
2022-12-31 $816,490 72,771
2022-09-30 $597,955 58,970
2022-06-30 $599,417 66,161
2022-03-31 $681,102 71,245
2021-12-31 $1,239,809 112,200
2021-09-30 $503,051 67,980
2021-06-30 $1,190,551 81,994
2021-03-31 $1,778,158 87,122
2020-12-31 $1,834,360 103,228
2020-09-30 $1,673,143 113,165
2020-06-30 $2,018,649 96,172
2020-03-31 $1,903,523 82,368